+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Glioblastoma Market and Competitive Landscape - 2020

  • ID: 5023429
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Glioblastoma Market and Competitive Landscape - 2020, provides comprehensive insights into the Glioblastoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Glioblastoma market size and drug sales. It also provides insights into Glioblastoma epidemiology and late stage pipeline.

This research covers the following: Glioblastoma treatment options, Glioblastoma late stage clinical trials pipeline, Glioblastoma prevalence by countries, Glioblastoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Glioblastoma pipeline: Find out drugs in clinical trials for the treatment of Glioblastoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Glioblastoma epidemiology: Find out the number of patients diagnosed (prevalence) with Glioblastoma by countries
  • Glioblastoma drugs: Identify key drugs marketed and prescribed for Glioblastoma in the US, including trade name, molecule name, and company
  • Glioblastoma drugs sales: Find out the sales value for Glioblastoma drugs by countries
  • Glioblastoma market valuations: Find out the market size for Glioblastoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Glioblastoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Glioblastoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Glioblastoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze Glioblastoma drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Glioblastoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Glioblastoma Treatment Options

2. Glioblastoma Pipeline Insights
2.1. Glioblastoma Phase 3 Clinical Trials
2.2. Glioblastoma Phase 2 Clinical Trials
2.3. Glioblastoma Phase 1 Clinical Trials

3. Glioblastoma Epidemiology Analysis by Countries

4. Germany Glioblastoma Market Insights
4.1. Marketed Drugs for Glioblastoma in Germany
4.2. Germany Glioblastoma Market Size & Forecast
4.3. Germany Glioblastoma Drugs Sales Forecast
4.4. Germany Glioblastoma Market Share Analysis

5. France Glioblastoma Market Insights
5.1. Marketed Drugs for Glioblastoma in France
5.2. France Glioblastoma Market Size & Forecast
5.3. France Glioblastoma Product Sales Forecast
5.4. France Glioblastoma Market Share Analysis

6. Italy Glioblastoma Market Insights
6.1. Marketed Drugs for Glioblastoma in Italy
6.2. Italy Glioblastoma Market Size & Forecast
6.3. Italy Glioblastoma Product Sales Forecast
6.4. Italy Glioblastoma Market Share Analysis

7. Spain Glioblastoma Market Insights
7.1. Marketed Drugs for Glioblastoma in Spain
7.2. Spain Glioblastoma Market Size & Forecast
7.3. Spain Glioblastoma Product Sales Forecast
7.4. Spain Glioblastoma Market Share Analysis

8. UK Glioblastoma Market Insights
8.1. Marketed Drugs for Glioblastoma in UK
8.2. UK Glioblastoma Market Size & Forecast
8.3. UK Glioblastoma Product Sales Forecast
8.4. UK Glioblastoma Market Share Analysis

9. Europe Glioblastoma Market Insights
9.1. Europe Glioblastoma Market Size & Forecast
9.2. Europe Glioblastoma Product Sales Forecast
9.3. Europe Glioblastoma Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Glioblastoma Phase 3 Clinical Trials, Global, 2020
Table 2: Glioblastoma Phase 2 Clinical Trials, Global, 2020
Table 3: Glioblastoma Phase 1 Clinical Trials, Global, 2020
Table 4: Glioblastoma Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Glioblastoma in Germany, 2019
Table 6: Germany Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Glioblastoma Product Sales ($mn), 2016 - 2024
Table 8: Germany Glioblastoma Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Glioblastoma in France, 2019
Table 10: France Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Glioblastoma Product Sales ($mn), 2016 - 2024
Table 12: France Glioblastoma Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Glioblastoma in Italy, 2019
Table 14: Italy Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Glioblastoma Product Sales ($mn), 2016 - 2024
Table 16: Italy Glioblastoma Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Glioblastoma in Spain, 2019
Table 18: Spain Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Glioblastoma Product Sales ($mn), 2016 - 2024
Table 20: Spain Glioblastoma Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Glioblastoma in UK, 2019
Table 22: UK Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Glioblastoma Product Sales ($mn), 2016 - 2024
Table 24: UK Glioblastoma Market Events and Trends, 2016 - 2024
Table 25: Europe Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Glioblastoma Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Glioblastoma Pipeline by Phase (%), Global, 2020
Figure 2: Glioblastoma Prevalence by Countries, 2016 - 2024
Figure 3: Germany Glioblastoma Market Size ($mn), 2016 - 2024
Figure 4: Germany Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 5: Germany Glioblastoma Market Share by Drugs (%), 2019
Figure 6: Germany Glioblastoma Market - Future Market Share (%), 2024
Figure 7: France Glioblastoma Market Size ($mn), 2016 - 2024
Figure 8: France Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 9: France Glioblastoma Market Share by Drugs (%), 2019
Figure 10: France Glioblastoma Market - Future Market Share (%), 2024
Figure 11: Italy Glioblastoma Market Size ($mn), 2016 - 2024
Figure 12: Italy Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 13: Italy Glioblastoma Market Share by Drugs (%), 2019
Figure 14: Italy Glioblastoma Market - Future Market Share (%), 2024
Figure 15: Spain Glioblastoma Market Size ($mn), 2016 - 2024
Figure 16: Spain Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 17: Spain Glioblastoma Market Share by Drugs (%), 2019
Figure 18: Spain Glioblastoma Market - Future Market Share (%), 2024
Figure 19: UK Glioblastoma Market Size ($mn), 2016 - 2024
Figure 20: UK Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 21: UK Glioblastoma Market Share by Drugs (%), 2019
Figure 22: UK Glioblastoma Market - Future Market Share (%), 2024
Figure 23: Europe Glioblastoma Market Size ($mn), 2016 - 2024
Figure 24: Europe Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 25: Europe Glioblastoma Market Share by Drugs (%), 2019
Figure 26: Europe Glioblastoma Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll